These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 31139999)

  • 1. S122: impact of fluorescence and 3D images to completeness of lateral pelvic node dissection.
    Kim HJ; Choi GS; Park JS; Park SY; Cho SH; Seo AN; Yoon GS
    Surg Endosc; 2020 Jan; 34(1):469-476. PubMed ID: 31139999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of indocyanine green-enhanced near-infrared fluorescence-guided imaging in laparoscopic lateral pelvic lymph node dissection for middle-low rectal cancer.
    Zhou SC; Tian YT; Wang XW; Zhao CD; Ma S; Jiang J; Li EN; Zhou HT; Liu Q; Liang JW; Zhou ZX; Wang XS
    World J Gastroenterol; 2019 Aug; 25(31):4502-4511. PubMed ID: 31496628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Robotic and laparoscopic salvage lateral pelvic node dissection for the treatment of recurrent rectal cancer.
    Kim HJ; Choi GS; Joshi H; Cho SH; Park JS; Park SY; Song SH; Kang MK
    Surg Endosc; 2023 Jun; 37(6):4954-4961. PubMed ID: 37016084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of Selective Lateral Node Dissection Based on Magnetic Resonance Imaging in Rectal Cancer After Preoperative Chemoradiotherapy.
    Park BK; Lee SJ; Hur BY; Kim MJ; Chan Park S; Chang HJ; Kim DY; Oh JH
    J Surg Res; 2018 Dec; 232():227-233. PubMed ID: 30463722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of FDG-PET/CT for lateral pelvic lymph node metastasis in rectal cancer treated with preoperative chemoradiotherapy.
    Ishihara S; Kawai K; Tanaka T; Kiyomatsu T; Hata K; Nozawa H; Morikawa T; Watanabe T
    Tech Coloproctol; 2018 May; 22(5):347-354. PubMed ID: 29623475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of lateral pelvic lymph node dissection for middle-low rectal cancer patients with lateral pelvic lymph node metastasis: a propensity score matching study.
    Zhou S; Jiang Y; Pei W; Liang J; Zhou Z
    BMC Cancer; 2022 Feb; 22(1):136. PubMed ID: 35109810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective lateral pelvic lymph node dissection: a comparative study of the robotic versus laparoscopic approach.
    Kim HJ; Choi GS; Park JS; Park SY; Lee HJ; Woo IT; Park IK
    Surg Endosc; 2018 May; 32(5):2466-2473. PubMed ID: 29124406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term clinical outcomes of total mesorectal excision and selective lateral pelvic lymph node dissection for advanced low rectal cancer: a comparative study of a robotic versus laparoscopic approach.
    Song SH; Choi GS; Kim HJ; Park JS; Park SY; Lee SM; Choi JA; Seok HA
    Tech Coloproctol; 2021 Apr; 25(4):413-423. PubMed ID: 33594627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined laparoscopic lymphoadenectomy of lateral pelvic and inguinal nodal metastases using indocyanine green fluorescence imaging guidance in low rectal cancer after preoperative chemoradiotherapy: a case report.
    Sun Y; Lin Y; Liu Z; Jiang W; Chi P
    BMC Gastroenterol; 2022 Mar; 22(1):123. PubMed ID: 35296259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Impact of Lateral Pelvic Node Dissection on the Survival of Patients in Low Rectal Cancer Subgroups Based on Lymph Node Size.
    Hida K; Nishizaki D; Sumii A; Okamura R; Sakai Y; Konishi T; Akagi T; Yamaguchi T; Akiyoshi T; Fukuda M; Yamamoto S; Arizono S; Uemura M; Hasegawa H; Kawada K; Morita S; Watanabe M;
    Ann Surg Oncol; 2021 Oct; 28(11):6179-6188. PubMed ID: 34255243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemoradiotherapy affects the indications for lateral pelvic node dissection in mid/low rectal cancer with clinically suspected lateral node involvement: a multicenter retrospective cohort study.
    Oh HK; Kang SB; Lee SM; Lee SY; Ihn MH; Kim DW; Park JH; Kim YH; Lee KH; Kim JS; Kim JW; Kim JH; Chang TY; Park SC; Sohn DK; Oh JH; Park JW; Ryoo SB; Jeong SY; Park KJ
    Ann Surg Oncol; 2014 Jul; 21(7):2280-7. PubMed ID: 24604580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary experience with lateral pelvic lymph node dissection in locally advanced rectal cancer.
    Sinukumar S; Engineer R; Saklani A
    Indian J Gastroenterol; 2015 Jul; 34(4):320-4. PubMed ID: 26334237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncological Outcomes of Patients with Locally Advanced Rectal Cancer and Lateral Pelvic Lymph Node Involvement.
    Sapci I; Delaney CP; Liska D; Amarnath S; Kalady MF; Steele SR; Gorgun E
    J Gastrointest Surg; 2019 Jul; 23(7):1454-1460. PubMed ID: 31012043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of lateral pelvic lymph node dissection in advanced rectal cancer: a review of current evidence and outcomes.
    Choi GS; Kim HJ
    Ann Coloproctol; 2024 Aug; 40(4):363-374. PubMed ID: 39228199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncological benefit of lateral pelvic lymph node dissection for rectal cancer treated without preoperative chemoradiotherapy: a multicenter retrospective study using propensity score analysis.
    Ishihara S; Kanemitsu Y; Murono K; Otani K; Yasuda K; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Hata K; Nozawa H; Kazama S; Yamaguchi H; Sunami E; Sugihara K; Watanabe T
    Int J Colorectal Dis; 2016 Jul; 31(7):1315-21. PubMed ID: 27240821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes of indocyanine green fluorescence imaging-guided laparoscopic lateral pelvic lymph node dissection for clinical stage II/III middle-lower rectal cancer: a propensity score-matched cohort study.
    Watanabe J; Ohya H; Sakai J; Suwa Y; Goto K; Nakagawa K; Ozawa M; Ishibe A; Suwa H; Kunisaki C; Endo I
    Tech Coloproctol; 2023 Sep; 27(9):759-767. PubMed ID: 36773172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short- and long-term outcomes of laparoscopic versus open selective lateral pelvic lymph node dissection for locally advanced middle-low rectal cancer: Results of a multicentre lateral node study in China.
    Tang J; Zhou S; Zhao W; Lou Z; Liang J; Feng B; Yang Y; Wang X; Liu Q;
    Colorectal Dis; 2022 Nov; 24(11):1325-1334. PubMed ID: 35713974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Robotic pelvic side-wall dissection and en-bloc excision for locally advanced and recurrent rectal cancer: outcomes on feasibility and safety.
    Lokuhetty N; Larach JT; Rajkomar AKS; Mohan H; Waters PS; Heriot AG; Warrier SK
    ANZ J Surg; 2022 Sep; 92(9):2185-2191. PubMed ID: 35555959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pay attention to the selective lateral pelvic lymph node dissection in mid-low rectal cancer].
    Meng W; Wang Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Mar; 20(3):258-262. PubMed ID: 28338156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term outcomes of near-infrared imaging using indocyanine green in laparoscopic lateral pelvic lymph node dissection for middle-lower rectal cancer: A propensity score-matched cohort analysis.
    Dai JY; Han ZJ; Wang JD; Liu BS; Liu JY; Wang YC
    Front Med (Lausanne); 2022; 9():1039928. PubMed ID: 36438036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.